Search research articles
Contact Us
Filters
Showing results (71-80 of 121) with videos related to
Page
of 13
Sort By:
Journal of the National Cancer Institute
|
November 20, 2010
Effect of nitroxoline on angiogenesis and growth of human bladder cancer
Joong Sup Shim, Yoshiyuki Matsui, Shridhar Bhat, et al.
Urologic Oncology
|
September 24, 2021
Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborative
Benjamin Shiff, Rodney H Breau, Ranjeeta Mallick, et al.
Urologic Oncology
|
July 10, 2019
Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis
Madhur Nayan, Shreya Jalali, Anil Kapoor, et al.
Oncotarget
|
April 13, 2018
Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinoma
Sebastian Frees, Ines Breuksch, Tobias Haber, et al.
Urology
|
June 15, 2021
Adrenalectomy During Radical Nephrectomy- Incidence and Oncologic Outcomes From the Canadian Kidney Cancer Information System (CKCis) -A Modern Era, Nationwide, Multicenter Cohort
Arnon Lavi, Rodney H Breau, Ranjeeta Mallick, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
February 8, 2021
2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC)
Fred Saad, Armen Aprikian, Antonio Finelli, et al.
Urologic Oncology
|
June 10, 2019
Morphologic subtyping as a prognostic predictor for survival in papillary renal cell carcinoma: Type 1 vs. type 2
Emily C L Wong, Richard Di Lena, Rodney H Breau, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 12, 2019
2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC)
Fred Saad, Armen Aprikian, Antonio Finelli, et al.
BJU International
|
October 11, 2019
Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostates
David-Dan Nguyen, Neil Barber, Mo Bidair, et al.
Urology
|
April 26, 2022
WATER vs WATER II 3-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc Prostates
Anis Assad, David-Dan Nguyen, Neil Barber, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 121) with videos related to
Sort By:
Page
of 13
Journal of the National Cancer Institute
|
November 20, 2010
Effect of nitroxoline on angiogenesis and growth of human bladder cancer
Joong Sup Shim, Yoshiyuki Matsui, Shridhar Bhat, et al.
Urologic Oncology
|
September 24, 2021
Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborative
Benjamin Shiff, Rodney H Breau, Ranjeeta Mallick, et al.
Urologic Oncology
|
July 10, 2019
Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis
Madhur Nayan, Shreya Jalali, Anil Kapoor, et al.
Oncotarget
|
April 13, 2018
Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinoma
Sebastian Frees, Ines Breuksch, Tobias Haber, et al.
Urology
|
June 15, 2021
Adrenalectomy During Radical Nephrectomy- Incidence and Oncologic Outcomes From the Canadian Kidney Cancer Information System (CKCis) -A Modern Era, Nationwide, Multicenter Cohort
Arnon Lavi, Rodney H Breau, Ranjeeta Mallick, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
February 8, 2021
2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC)
Fred Saad, Armen Aprikian, Antonio Finelli, et al.
Urologic Oncology
|
June 10, 2019
Morphologic subtyping as a prognostic predictor for survival in papillary renal cell carcinoma: Type 1 vs. type 2
Emily C L Wong, Richard Di Lena, Rodney H Breau, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 12, 2019
2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC)
Fred Saad, Armen Aprikian, Antonio Finelli, et al.
BJU International
|
October 11, 2019
Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostates
David-Dan Nguyen, Neil Barber, Mo Bidair, et al.
Urology
|
April 26, 2022
WATER vs WATER II 3-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc Prostates
Anis Assad, David-Dan Nguyen, Neil Barber, et al.
Page
of 13